Loading activity…
@afshineemrani
Heart doctor in Tarzana, LA. I write about longevity, medicine and what patients teach us. Live longer. Live wiser. 👇 Become a patient or subscribe
Science
Science says the approach begins with a patient’s chief complaint and helps physicians decide which questions and tests follow.
Science
A cardiologist, citing Nature Medicine on September 16, 2026, describes results from 1,286 people in four countries—and cautions that the test is not ready for annual checkups.
Science
A cardiologist reports about a 53% LDL cholesterol reduction at the highest dose in a 15-patient Phase 1a trial of CTX310. The account stresses that larger, longer studies are needed and the therapy is not FDA-approved.